(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.79%) $83.19
(-1.16%) $1.619
(-0.39%) $2 338.10
(1.06%) $27.54
(0.67%) $928.30
(-0.19%) $0.933
(-0.15%) $11.01
(-0.23%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology...
Stats | |
---|---|
本日の出来高 | 49 808.00 |
平均出来高 | 105 757 |
時価総額 | 70.00B |
EPS | $0.450 ( 2023-11-08 ) |
Last Dividend | $0.472 ( 2023-05-02 ) |
Next Dividend | $0 ( N/A ) |
P/E | 23.20 |
ATR14 | $0.124 (0.38%) |
ボリューム 相関
MERCK 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
MERCK 相関 - 通貨/商品
MERCK 財務諸表
Annual | 2023 |
収益: | $20.99B |
総利益: | $11.67B (55.59 %) |
EPS: | $6.50 |
FY | 2023 |
収益: | $20.99B |
総利益: | $11.67B (55.59 %) |
EPS: | $6.50 |
FY | 2022 |
収益: | $22.23B |
総利益: | $13.71B (61.65 %) |
EPS: | $7.65 |
FY | 2021 |
収益: | $19.69B |
総利益: | $12.34B (62.66 %) |
EPS: | $1.405 |
Financial Reports:
No articles found.
MERCK Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.472 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.505 | 2008-03-26 |
Last Dividend | $0.472 | 2023-05-02 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-11 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | $4.47 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.45 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.15 | |
Div. Directional Score | 9.30 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TYFG | Ex Dividend Junior | 2023-09-28 | Quarterly | 0 | 0.00% | |
JRONY | Ex Dividend Knight | 2023-05-15 | Annually | 0 | 0.00% | |
BPOSY | Ex Dividend Knight | 2023-05-18 | Annually | 0 | 0.00% | |
RMYHY | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
FCELB | Ex Dividend Junior | 2023-07-31 | Semi-Annually | 0 | 0.00% | |
VWAPY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
LRENY | Ex Dividend Knight | 2023-06-30 | Quarterly | 0 | 0.00% | |
CKNQP | Ex Dividend Junior | 2023-09-14 | Quarterly | 0 | 0.00% | |
SKHHY | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
GTPS | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.135 | 1.500 | 7.31 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0575 | 1.200 | 8.08 | 9.70 | [0 - 0.3] |
returnOnEquityTTM | 0.105 | 1.500 | 9.95 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.440 | -1.000 | 5.60 | -5.60 | [0 - 1] |
currentRatioTTM | 1.425 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.822 | 0.800 | 9.87 | 7.90 | [0.8 - 2.5] |
cashRatioTTM | 0.228 | 1.500 | 9.85 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.194 | -1.500 | 6.76 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.33 | 1.000 | 6.92 | 6.92 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.70 | 2.00 | 7.10 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.52 | 2.00 | 7.74 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.358 | -1.500 | 8.57 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.590 | 1.000 | 3.50 | 3.50 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.182 | 1.000 | 8.36 | 8.36 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.396 | 1.000 | 8.91 | 8.91 | [0.2 - 2] |
assetTurnoverTTM | 0.427 | 0.800 | -0.484 | -0.387 | [0.5 - 2] |
Total Score | 12.44 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.64 | 1.000 | 9.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.105 | 2.50 | 9.97 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.52 | 2.00 | 8.49 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.566 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.70 | 2.00 | 7.10 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.440 | 1.500 | 5.60 | -5.60 | [0 - 1] |
pegRatioTTM | 0.0445 | 1.500 | -3.04 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.180 | 1.000 | 7.99 | 0 | [0.1 - 0.5] |
Total Score | 6.15 |
MERCK
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。